Moreover, diabetic heart cells showed significantly reduced expression of miR-181a and miR-30c and increased expression of their target genes p53 and p21, which are key regulators of cardiomyocyte hypertrophy, mediating the pro-hypertrophic effects of hyperglycemia (111). The gene discussed is TP53; the disease is Hyperglycemia.